Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway.
about
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesMitochondria as a therapeutic target in heart failureHeart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategiesThe renin-angiotensin system and prevention of age-related functional decline: where are we now?Mitochondrial hormesis and diabetic complicationsValsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions.Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats.Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats.The coactivator PGC-1α regulates skeletal muscle oxidative metabolism independently of the nuclear receptor PPARβ/δ in sedentary mice fed a regular chow diet.Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor δ (PPARδ): from bedside to benchAlternative Interventions to Prevent Oxidative Damage following Ischemia/ReperfusionCrosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria.ACE and response to pulmonary rehabilitation in COPD: two observational studies.Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease.Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.Activation of AMPK and its Impact on Exercise Capacity.Caffeoylquinic Acid-Rich Extract of Aster glehni F. Schmidt Ameliorates Nonalcoholic Fatty Liver through the Regulation of PPARδ and Adiponectin in ApoE KO Mice.Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.The effects of chronic candesartan treatment on cardiac and hepatic adenosine monophosphate-activated protein kinase in rats submitted to surgical stress.Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure.Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker.Angiotensin II receptor blocker improves the lowered exercise capacity and impaired mitochondrial function of the skeletal muscle in type 2 diabetic mice.
P2860
Q26767412-7AB656B2-E253-45C5-9410-B3D001A28F64Q27005632-35AA3AD9-20A9-4CE4-9C1E-462AEC91AB2CQ27005955-31790B6D-9033-4C88-9AB4-F20E006C231AQ28085528-E5F000C7-696E-4DAB-B34B-FD5006F6FD82Q28388387-81706228-372F-4E14-8EA4-9B243ADE7C34Q34571546-2B5A7E4E-9B16-4DA9-8604-F3988740837DQ35080208-758981D9-8624-4756-8FD1-BFF99885745FQ35981368-23D360CB-1447-4421-AD8F-80F9793E6357Q36310530-00B00A64-F369-4E72-81BA-4710F059CA7FQ37171547-CF6984C4-F865-4855-B51A-0E7AD239829CQ37578724-53110D74-E65D-4CF1-9A5F-58B70E87742BQ37694958-757B5D11-DB1C-43E6-8E1C-328F6E377917Q37704113-340BC784-2075-4348-BDBC-03424DF55769Q38023517-04908DD3-D118-4522-B57C-D2DE8BF5E58CQ38454084-B9E52CB4-51A2-4121-8566-F8DAC4149C11Q38549546-23B82D6D-5B9A-4EF4-AE87-CDF64FD6D031Q46248847-3093C237-BA2C-4C34-97A9-1C09B4B92F59Q47141643-1D97ACB5-0C24-4E65-91A9-30AAE5D54968Q47768588-8708130C-E72F-45C7-B242-76380F3C8F12Q48023234-D9F6CB19-E9EF-49AC-8DE6-C1F348967B91Q48198351-A2A2D034-54B3-40AB-8FD8-82C6832915A8Q53124062-91FA4AB5-E498-4B8C-81A8-FC3D81F2D805
P2860
Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@ast
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@en
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@nl
type
label
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@ast
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@en
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@nl
prefLabel
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@ast
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@en
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@nl
P2093
P2860
P1476
Angiotensin II receptor blocke ...... on of the PPAR-δ/AMPK pathway.
@en
P2093
Dachun Yang
Daoyan Liu
Shuangtao Ma
Tingbing Cao
Xiaoli Feng
Zhencheng Yan
Zhidan Luo
Zhigang Zhao
P2860
P304
P356
10.1111/J.1582-4934.2010.01085.X
P577
2010-05-14T00:00:00Z